Key Insights

Highlights

Treatment Research

16 treatments under study, led by Topotecan It

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06942039Early Phase 1Recruiting

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

Showing all 1 trials

Research Network

Common Treatments

  • Topotecan It1
  • Mesna1
  • Tamoxifen1
  • Thiotepa1
  • Temozolomide1

Active Sponsors

  • C17 Council1

Top Investigators

Related Conditions

  • Atypical Teratoid Rhabdoid Tumor1
  • Medulloepithelioma1
  • Ependymoblastoma1
  • Medulloblastoma Group 41
  • Embryonal Tumor With Multilayered Rosettes1

Activity Timeline